key: cord-0733954-yxxcup06
authors: Chan, Kevin Ivan P.; Ignacio, Katrina Hannah D.; Omar, Abdelsimar Tan; Khu, Kathleen Joy O.
title: Top 100 most cited neurologic and neurosurgical articles on COVID-19: a bibliometric analysis
date: 2021-10-04
journal: World Neurosurg
DOI: 10.1016/j.wneu.2021.09.118
sha: 919f167904c93f97c2d6a06920e6f0cc9b77c39f
doc_id: 733954
cord_uid: yxxcup06

Objective With the exponential growth of coronavirus 2019 (COVID-19) related literature, we aimed to identify and characterize the 100 most cited COVID-related articles in the field of neurology and neurosurgery. Methods In March 2021, we performed a title-specific search of the Scopus database using the terms (“neurology” or “neurologic” or “neurosurgery” or “neurosurgical”) and “COVID” as our search query term without date restrictions. The top 100 most cited English-language articles were obtained and reviewed. Results Our search yielded 9,648 articles published from December 2019 to March 2021. Bibliometric analysis of the top 100 articles found that (1) the most cited article had a citation count of 1741 and was the first to report on the detailed neurologic manifestations of the disease; (2) Neurology had the most number of publications; (3) the majority of the primary authors were neurologists, but 35% came from non-neuroscience specialties; (4) the United States of America, Italy, United Kingdom, China, and Germany were the top contributors, with a combined total of 77%; (5) most of the publications were correspondence or editorial articles; and (6) most articles discussed the neurologic manifestations and complications of patients with COVID-19. Conclusions This study has identified the top 100 most cited neurologic or neurosurgical COVID-19-related articles published to date. This list can be used to identify high impact studies that will help healthcare practitioners in clinical decision making and researchers in navigating key areas of study and guiding future research.

In December 2019, the first case of coronavirus disease 2019 was reported in Wuhan, China. 1 In a span of just one year, the causative infectious agent SARS-CoV-2 has infected more than 100 million people and claimed more than 2 million lives worldwide, making it the most challenging global health crisis of the century. 2 Aside from the massive healthcare response, the international scientific community has also responded to this novel disease promptly and vigorously, with over 450,000 articles 3 published about the disease in a little over a year since its first emergence, and the number of articles have been increasing exponentially.

Despite being a primarily respiratory illness, COVID-19 has been found to involve other organ systems such as gastrointestinal 4 , hepatobiliary 4 , cardiovascular 5 , dermatologic 6 , renal 7 , hematologic 8 , ophthalmologic 9 , and neurologic 10 . One of the earliest studies on the neurologic manifestations of the disease found that as high as 36.4% of patients with COVID-19 presented with central nervous system symptoms, while 8.9% had peripheral nervous system involvement. 11 Since then, COVID-19 patients have been reported to exhibit various neurologic manifestations and sequelae, and the virus has been implicated in a wide array of neurologic diseases. 12 With the exponential growth of COVID-19-related literature, highlighting the most impactful papers in the neurosciences becomes imperative. Identifying key studies would help clinicians in evidence-based decision making, and researchers in mapping out what is known about the neurologic manifestations of the disease. In this study, we performed a bibliometric analysis to identify and determine the characteristics of the top 100 most cited neurologic or neurosurgical COVID-19-related articles published to date. J o u r n a l P r e -p r o o f

We performed a title-specific search of the SCOPUS database to identify highly cited articles in the field of neurology and neurosurgery in relation to COVID-19 in March 2021. We used ("neurology" or "neurologic" or "neurosurgery" or "neurosurgical") and "COVID" as our query term.

English-language articles reporting on any neurologic aspect of the disease (clinical or radiologic features, health service delivery, pathophysiology, medical or surgical treatment) were included in the study. Indexed articles that were conference proceedings or book chapters were excluded.

The results were arranged in descending order according to the citation count. The top 100 most cited articles were obtained and reviewed by the authors. Two reviewers screened all studies based on study titles and abstracts available, and evaluated the articles independently.

The article title, primary author, primary author's specialty, institution, country of origin, journal of publication, citation count, study category, and content were obtained for the top 100 most cited articles. Study categories included case reports, case series, prospective or retrospective cohort studies, reviews (systematic reviews, narrative reviews, or meta-analyses), of listed citations and the scientific reputation of the journal. 13 When the authors of an article have more than one affiliation, the department, institution, and country of origin were defined by the affiliation of the first author of the said study. Data was presented using descriptive statistics. The articles were published in a total of 60 different journals, with Neurology having the most number of publications (n=7), closely followed by JAMA Neurology (n=6) ( Table 2 ). The overwhelming majority of the primary authors were neurologists (n=54), followed by otorhinolaryngologists (n=11), neurosurgeons (n=6), and radiologists (n=6) ( Table 3) . Two authors had multiple publications in the list: Vaira LA with three articles (Rank 11, 68, 100) and

Zhao J with two (Rank 51, 74).

The top 100 articles originated from 19 different countries (Table 4) , with the United States contributing 32 articles, followed by Italy (16) , United Kingdom (14) , China (12) , and Germany (5) . Institution-wise, Harvard Medical School in Boston, USA and University Hospital of Sassari in Sassari, Italy contributed the most papers at 4 and 3 each, respectively ( Table 5) .

Most of the articles written were correspondence or editorial articles, followed by reviews and retrospective studies ( Figure 1 ). More than half of the papers described the clinical features and outcomes of the neurologic manifestations and system involvement in COVID-19 cases ( Figure 2 ).

To the best of our knowledge, the present bibliometric analysis is the first to focus on COVID-19 articles in the field of neurology and neurosurgery. We have identified the seminal papers that may help healthcare practitioners in their clinical decision making for COVID-19 patients presenting with nervous system involvement. We also hope that the list would guide researchers in navigating the areas of importance and identify the current gaps in knowledge in the clinical neurosciences.

The large number of articles that were found after the search and the high number of citations for the top hundred papers point to the unprecedented volume of studies that have been done on the various aspects of COVID-19. 14 This reflects the vigorous response of the international scientific community to the disease that has become the greatest public health threat faced by nations across the world. (Table 2) .

Among the specialties, neurology contributed the most to the top 100 cited articles, as expected. The other neuroscience allied specialties (neurosurgery, neuropsychiatry, basic neurosciences) combined with neurology to comprise 65% of the top articles. However, it is noteworthy that a number of non-neurologic specialties have produced impactful articles as well, with the other 35% written by authors from non-neuroscience specialties, such as otorhinolaryngology, radiology, and pathology. This finding reflects and underscores the multidisciplinary approach to managing COVID-19. 16 Five countries were responsible for 77% of the studies. This is consistent with the results of other bibliometric analyses which place China, USA, Italy, and the UK among the top 4 countries with COVID-related researches. [16] [17] [18] Intuitively, China had a significant proportion of the most cited papers because it is where the disease was first described. Similarly, Italy was one of the early hotspots of the pandemic. The burden of disease in the USA and UK peaked at the end of 2020 [18] [19] [20] , resulting in a larger number of COVID-19 patients. The USA, UK, Italy, and Germany are also classified as high income countries, who spend a greater percentage of their GDP on research and development compared to lower income countries. 21 They have also been J o u r n a l P r e -p r o o f identified as scientifically advanced countries, with the most positive ranking in terms of scientific capacity. 22, 23 Another finding was that 36% of the papers published in the list were multi-country collaborations. A report on research productivity output in pre-COVID times showed that one out of five publications involved more than one country, 24 but in our bibliometric analysis, the ratio increased to one out of three. 23 These publications had an average of 2.1 collaborations between authors from different countries, but the study with the most number involved authors from 10 different countries. 25 In this paper, the authors recommended the establishment of local and international registries to report COVID-19 cases with neurologic manifestations to help define the true neuroepidemiological status of the disease. 25 These collaborations highlight the active involvement and scientific globalism in response to the crisis. 26 A review of the 2 nd to 5 th most cited studies in the series showed that all were published during the early part of the pandemic (February to April of 2020). The 2 nd most cited study was the first to elaborate on the neuroinvasive potential of the disease and proposed a model of how the virus affected the central nervous system. 28 The 3 rd to 5 th most cited studies reported novel neurologic manifestations of COVID-19. [29] [30] [31] It was previously thought that the virus merely affected the respiratory system and spared the nervous system, but this was proven to be incorrect as more and more articles shed light onto the spectrum of neurological signs and symptoms brought about by COVID-19. 32 In fact, more than half of the studies (53%) in the analysis were descriptions of the neurologic involvement in COVID-19 and their outcomes. The rest of the articles discussed health service delivery (21%), pathophysiologic mechanisms (15%), radiologic findings (6%), and treatment (5%). (Figure 2) One of the most important neurologic symptoms distinctly associated with COVID-19 was olfactory dysfunction, which was discussed in 13 out of the 100 articles. Moein et al. even suggested that smell dysfunction was a potential biomarker for COVID-19 infection and could be used in some cases to identify patients in need of early treatment or quarantine. 33 42 and they have been found to occur in COVID-19 patients who were younger than 50 years old. 30 It was postulated that hypercoagulability and endothelial dysfunction contributed to strokes in COVID-19, 43 and the presence of cerebrovascular disease in COVID patients has been suggested to be a negative prognostic factor. 42, 43 Twenty-one studies discussed the impact of the pandemic on patients with neurologic diseases such as stroke, demyelinating disease, movement disorder, and neuromuscular disorder.

There was concern over fewer acute stroke patients going to the hospital for fear of contracting the infection, resulting in treatment delays 44 . It was also during the pandemic that the protected stroke code was developed and implemented. Khosravani et al. presented an algorithm developed for stroke codes in pandemic times that involved screening, personal protective equipment, and crisis resource management, and this was adapted in other institutions as well. 45 Out of the top 100, there were 5 articles that discussed the impact of COVID-19 on neurosurgery. These articles highlighted the reorganization and adjustment that neurosurgeons faced during the pandemic, and described the shift in practices. Two articles focused on endoscopic procedures that posed an additional, unique risk to neurosurgeons due to the high nasal viral titers and potential for aerosol generation during nasal surgery. The authors advocated the safety of the surgical team and proposed recommendations and mitigation strategies. 46 

Global Trends in Epidemiology of Coronavirus Disease 2019 (COVID-19)

COVID-19: Current knowledge in clinical features, immunological responses, and vaccine development

Digital Science. Dimensions COVID-19 Report Dimensions COVID-19 Report

Gastrointestinal, hepatobiliary, and pancreatic manifestations of COVID-19

Cardiac and arrhythmic complications in patients with COVID-19

Skin Manifestations Associated with COVID-19: Current Knowledge and Future Perspectives

Nephrology and COVID-19

Haematological manifestations of COVID-19: From cytopenia to coagulopathy

COVID-19 and Eye: A Review of

Ophthalmic Manifestations of COVID-19

Neurological Manifestations in COVID-19 Infection: A Systematic Review and Meta-Analysis

Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease

Neurological complications of coronavirus infection; a comparative review and lessons learned during the COVID-19 pandemic

The 100 Most Cited Papers About Brain Metastases

Unprecedented surge in publications related to COVID-19 in the first three months of pandemic: A bibliometric analytic report

COVID-19 and neurologic disease

Coronavirus disease (COVID-19): A machine learning bibliometric analysis

Early Research on COVID-19: A Bibliometric Analysis

Mapping the situation of research on coronavirus disease-19 (COVID-19): A preliminary bibliometric analysis during the early stage of the outbreak

Global Epidemiology of First 90 Days into COVID-19 Pandemic: Disease Incidence, Prevalence, Case Fatality Rate and Their Association with Population Density, Urbanisation and Elderly Population

Comparing the scope and efficacy of covid-19 response strategies in 16 countries: An overview

World Development Report 2021: Data for Better Lives

Building Capacity in Developing Countries?

Scientific globalism during a global crisis: research collaboration and open access publications on COVID-19. High Educ

The neurology of COVID-19 revisited: A proposal from the Environmental Neurology Specialty Group of the World Federation of Neurology to implement international neurological registries

International collaboration and covid-19: what are we doing and where are we going

Neurological Manifestations of Hospitalized Patients with COVID-19 in Wuhan, China: A Retrospective Case Series Study

The neuroinvasive potential of SARS-CoV2 may play a role in the respiratory failure of COVID-19 patients

Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study

Large-Vessel Stroke as a Presenting Feature of Covid-19 in the Young

A first case of meningitis/encephalitis associated with SARS-Coronavirus-2

Neurology and COVID-19

Smell dysfunction: a biomarker for COVID-19

Guillain-Barré syndrome related to COVID-19 infection

Guillain Barre syndrome associated with COVID-19 infection: A case report

Guillain-Barré Syndrome associated with SARS-CoV-2 infection

COVID-19 may induce Guillain-Barré syndrome

Miller Fisher syndrome and polyneuritis cranialis in COVID-19

Focal status epilepticus as unique clinical feature of COVID-19: A case report

COVID-19-related acute necrotizing encephalopathy with brain stem involvement in a patient with aplastic anemia

Meningoencephalitis without respiratory failure in a young female patient with COVID-19 infection in Downtown Los Angeles

Acute cerebrovascular disease following COVID-19: a single center, retrospective, observational study

COVID-19-Related Stroke

Analysis of nationwide stroke patient care in times of COVID-19 pandemic in Germany

Protected Code Stroke: Hyperacute Stroke Management during the Coronavirus Disease 2019 (COVID-19) Pandemic

Endonasal instrumentation and aerosolization risk in the era of COVID-19: simulation, literature review, and proposed mitigation strategies

Letter: Precautions for Endoscopic Transnasal Skull Base Surgery during the COVID-19 Pandemic

Letter: The Coronavirus Disease 2019 Global Pandemic: A Neurosurgical Treatment Algorithm

Characteristics of scientific articles on COVID-19 published during the initial 3 months of the pandemic

Scientometric trends for coronaviruses and other emerging viral infections. bioRxiv

This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.

J o u r n a l P r e -p r o o f